"Key Account Management Excellence in Pharma & Medtech is designed to help life sciences practitioners develop and execute innovative and effective key account management (KAM) strategies and capabilities. Pharmaceutical and medtech companies are increasingly pursuing KAM in response to the rapid rise of large, sophisticated and complex healthcare provider and payer systems and groups. Those that invest the time to get KAM right will protect their business and grow with these rising customers. This book is groundbreaking in both its scope and its tailoring of leading KAM practices specifically for life sciences. The central theme is that "key account management is an organization-wide business strategy, not just a role or a sales-specific initiative." KAM is a strategy focused on providing unique offerings and value through an orchestrated, cross-functional, go-to-market model designed specifically to address the needs and engagement preferences of a unique segment of customers. The insights and practices shared in this book are designed to be a valuable reference at every stage of the KAM journey. The book has been designed to facilitate a common language and deep understanding of KAM issues and leading practices organization-wide-particularly for life sciences leaders, account managers and cross-functional team members responsible for building, transforming and supporting their organization's KAM strategies and capabilities"--
Pharmaceutical and medtech companies are increasingly pursuing key account management (KAM) in response to the rise of large, sophisticated and complex healthcare provider and payer systems and groups. Those that invest the time to get KAM right will protect their business and grow with these rising customers, and this book shows you how.
|
List of figures and tables |
|
|
xiii | |
| Foreword---A message from the CEO of SAMA |
|
xvii | |
| Preface---Important information about this book |
|
xxi | |
|
Chapter 1 Kam Is A Business Strategy, Not A Role |
|
|
1 | (8) |
|
|
|
|
|
Chapter 2 The Rise Of The Organized Customer And Kam In Healthcare |
|
|
9 | (12) |
|
|
|
|
|
Chapter 3 Where To Play: Key Account Segmentation And Selection |
|
|
21 | (20) |
|
|
|
|
|
Chapter 4 Value Strategy: Evolving From Basic Offerings To Advanced Solutions |
|
|
41 | (18) |
|
|
|
|
|
|
|
Chapter 5 Kam Organization Design: Form Follows Function |
|
|
59 | (8) |
|
|
|
|
|
Chapter 6 Executive Alignment And Engagement: It'S Make Or Break For Life Sciences Kam Programs |
|
|
67 | (14) |
|
|
|
|
|
Chapter 7 Kam Program Office: Marshalling The Internal Support Required For Results |
|
|
81 | (12) |
|
|
|
Chapter 8 The Long And Short Of Kam Metrics |
|
|
93 | (10) |
|
|
|
|
|
|
|
Chapter 9 Customer Engagement Process: The Secret To Agile Execution |
|
|
103 | (10) |
|
|
|
|
|
Chapter 10 Bringing Value To Account Planning And Management |
|
|
113 | (12) |
|
|
|
|
|
|
|
Chapter 11 Context Is King: Laying The Foundation For A Comprehensive Kam Talent Strategy |
|
|
125 | (8) |
|
|
|
|
|
|
|
Chapter 12 The Unique Learning Journey Required For Kam |
|
|
133 | (14) |
|
|
|
|
|
|
|
Chapter 13 Key Account Manager Incentive Compensation: Aligning To Strategic Objectives |
|
|
147 | (16) |
|
|
|
|
|
|
|
Chapter 14 Why Technology Is Critical For Breathing Life Into Kam |
|
|
163 | (12) |
|
|
|
|
|
|
|
Chapter 15 Kam In The United States Versus Europe: Are We Headed To The Same Place? |
|
|
175 | (10) |
|
|
|
|
|
Chapter 16 The Future Of Kam In Life Sciences |
|
|
185 | (16) |
|
|
|
|
|
|
|
|
| About the authors |
|
201 | (8) |
| Acknowledgments |
|
209 | (2) |
| Index |
|
211 | |
Mike Moorman is a Principal at ZS and leads the firms key account management practice. Mike founded ZSs B2B commercial strategy and transformation practice and is a recognized expert in his field. He has worked globally and with more than 50 B2B organizations across 12 industries. Mike serves on the Board of Directors and the Research Advisory Board for the Strategic Account Management Association, and is an Adjunct Lecturer on Sales Strategy at Northwesterns Kellogg Executive Program. Mike has authored more than 60 publications and has been cited in leading publications including Harvard Business Review, Financial Times, The Wall Street Journal, IndustryWeek, USA Today and Selling Power.